Calcium folinate pentahydrate
T-cell Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)Small moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the T-cell Childhood Acute Lymphoblastic Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
METHOTREXATE National Cancer Institute (NCI) | Phase 3 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 3 | BB |
ETOPOSIDE National Cancer Institute (NCI) | Phase 3 | BB |
ASPARAGINASE National Cancer Institute (NCI) | Phase 3 | BB |
Cytosin-Arabinosid National Cancer Institute (NCI) | Phase 3 | BB |
View all 28 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →